Giuseppe Lanzarone

4PUBLICATIONS
33CO-AUTHORS
Molecular targetsGene and molecular therapyRegenerative medicine (incl. stem cells)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 08, 2026
Roginolisib in Combination with JAK Inhibitors in Patients with Myelofibrosis Who are Unresponsive to Approved JAK Inhibitors (Study HEMA-MED) - A Trial in Progress.

|Sep 13, 2025
Integration of Next-Generation Sequencing in Measurable Residual Disease Monitoring in Acute Myeloid Leukemia and Myelodysplastic Neoplasm.

Elena Crisà, Irene Dogliotti, Giuseppe Lia

|Dec 08, 2022
Biosimilar erythropoiesis-stimulating agents are an effective and safe option for the management of myelofibrosis-related anemia.

Elena Inzoli, Elena Crisà, Novella Pugliese

|Aug 27, 2021
The Prognostic Role of Cytogenetics Analysis in Philadelphia Negative Myeloproliferative Neoplasms.

Giuseppe Lanzarone, Matteo Olivi

Pageof 1

Frequent Collaborators

2 joint publications

Elena Crisà

1 joint publications

Elena Inzoli

1 joint publications

Novella Pugliese

1 joint publications

Ivan Civettini